Connor, Clark & Lunn Investment Management (CC&L)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-26,495
| Closed | -$202K | – | 1246 |
|
|
2021
Q3 | $202K | Buy |
+26,495
| New | +$202K | ﹤0.01% | 947 |
|
|
2018
Q2 | – | Sell |
-118,685
| Closed | -$611K | – | 1120 |
|
|
2018
Q1 | $611K | Buy |
+118,685
| New | +$611K | ﹤0.01% | 542 |
|
|
2016
Q1 | – | Sell |
-16,900
| Closed | -$147K | – | 920 |
|
|
2015
Q4 | $147K | Buy |
+16,900
| New | +$147K | ﹤0.01% | 726 |
|